Multidimensional assessment and tailored interventions for COPD: Respiratory utopia or common sense?

Thorax

Volumn 68, Issue 7, 2013, Pages 691-694

  McDonald, Vanessa M ^a,b,c   Higgins, Isabel ^a   Wood, Lisa G ^c,d   Gibson, Peter G ^b,d,e  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c JOHN HUNTER HOSPITAL   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BECLOMETASONE; CORTICOSTEROID; DOXYCYCLINE; PREDNISOLONE; SIMVASTATIN; SODIUM CHLORIDE;

AGED; CASE MANAGEMENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; EOSINOPHIL; FEMALE; HEALTH STATUS; HUMAN; INFLAMMOMETRY; LUNG FUNCTION; MALE; MEDICAL DECISION MAKING; MULTIDIMENSIONAL SCALING; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT INFLAMMATION; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT INDICATION; TREATMENT PLANNING;

COPD PHARMACOLOGY; SYSTEMIC DISEASE AND LUNGS;

CASE MANAGEMENT; DISEASE MANAGEMENT; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84879411561     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-202646     Document Type: Review

References (29)

1. Buist SA, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50. (Pubitemid 47321907)
2. Mathers CVT, Stephenson C. The Burden of Disease and Injury in Australia. AIWH Cat. No. PHE-17. Canberra: Australian Institute of Health and Welfare. 1999.
3. Gibson PG, McDonald VM, Marks GB. Asthma in the older adult. Lancet 2010;374:803-13.
4. Antonelli Incalzi R, Pedone C, Pahor M. Multidimensional assessment and treatment of the elderly with COPD. Eur Respir Mon 2009:35-55.
5. Beasley R, Weatherall M, Travers J, et al. Time to define the disorders of the syndrome of COPD. Lancet 2009;29:670-2.
6. Guerra S. Asthma and chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol 2009;9:409-16.
7. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Vancouver: GOLD. 2011.
8. Albert RK, Connett J, Bailey WC, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med 2011;365:689-98.
9. Simpson JL, Powell H, Boyle MJ, et al. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 2008;177: 148-55.
10. Rubin BK, Henke MO. Immunomodulatory activity and effectiveness of macrolides in chronic airway disease. Chest 2004;125(2 Suppl):70S-8S.
11. Lee T-M, Lin M-S, Chang N-C. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardiol 2008;101:530-5. (Pubitemid 351199448)
12. Sin DD, Man SF, Marciniuk DD, et al. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177:1207-14. (Pubitemid 351860929)
13. Cowan DC, Cowan JO, Palmay R, et al. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax 2010;65:384-90.
14. Crim C, Calverley PM, Anderson JA, et al. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 2009;34:641-7.
15. McDonald VM, Higgins I, Simpson JL, et al. The importance of clinical management problems in older people with COPD and asthma; do patients and physicians agree? Prim Care Respir J 2011;20:389-95.
16. McDonald VM, Simpson JL, Higgins I, et al. Multidimensional assessment of older people with asthma & COPD: clinical management and health status. Age Ageing 2011;40:42-9.
17. McDonald VM, Higgins I, Gibson PG. Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges. Drugs Aging 2012;11:11.
18. Powell H, Murphy VE, Taylor DR, et al. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. Lancet 2011;378:983-90.
19. Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360:985-93.
20. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;30:1715-21. (Pubitemid 35447900)
21. Jayaram L, Pizzichini MM, Cook RJ, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006;27:483-94. (Pubitemid 43372521)
22. Siva R, Green RH, Brightling CE, et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J 2007;29:906-13. (Pubitemid 46711894)
23. Petsky HL, Kynaston JA, Turner C, et al. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 2007; (2): CD005603.
24. Blamoun AI, Batty GN, DeBari VA, et al. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study. Int J Clin Pract 2008;62:1373-8.
25. Keddissi JI, Younis WG, Chbeir EA, et al. The use of statins and lung function in current and former smokers. Chest 2007;132:1764-71.
26. Mancini GB, Etminan M, Zhang B, et al. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 2006;47:2554-60. (Pubitemid 43866389)
27. Lee T-M, Chen C-C, Shen H-N, et al. Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Clin Sci 2009;116:497-505.
28. Frost FJ, Petersen H, Tollestrup K, et al. Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest 2007;131: 1006-12. (Pubitemid 46608700)
29. Ishida W, Kajiwara T, Taneichi H, et al. Decrease in mortality rate of chronic obstructive pulmonary disease (COPD) with statin use: a population-based analysis in Japan. Tohoku J Exp Med 2007;212:265-73. (Pubitemid 47304993)